Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

278 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single agent docetaxel plus granulocyte-colony stimulating factor (G-CSF) in previously treated patients with advanced non small cell lung cancer. A phase II study and review of the literature.
Gridelli C, Frontini L, Barletta E, Rossi A, Barzelloni ML, Scognamiglio F, Guida C, Gatani T, Fiore F, De Bellis M, Marfella A, Manzione L. Gridelli C, et al. Among authors: de bellis m. Anticancer Res. 2000 Mar-Apr;20(2B):1077-84. Anticancer Res. 2000. PMID: 10810400 Review.
Ischemic colitis associated with paclitaxel.
Daniele B, Rossi GB, Losito S, Gridelli C, de Bellis M. Daniele B, et al. Among authors: de bellis m. J Clin Gastroenterol. 2001 Aug;33(2):159-60. doi: 10.1097/00004836-200108000-00015. J Clin Gastroenterol. 2001. PMID: 11468447
Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review.
Di Girolamo E, Belli A, Ottaiano A, Granata V, Borzillo V, Tarotto L, Tatangelo F, Palaia R, Civiletti C, Piccirillo M, D'Angelo V, Fiore F, Marone P, Nasti G, Izzo F, de Bellis M. Di Girolamo E, et al. Among authors: de bellis m. Front Oncol. 2023 May 30;13:1077794. doi: 10.3389/fonc.2023.1077794. eCollection 2023. Front Oncol. 2023. PMID: 37324013 Free PMC article. Review.
Treatments, prognostic factors, and genetic heterogeneity in advanced cholangiocarcinoma: A multicenter real-world study.
Ottaiano A, Santorsola M, Diana A, Belli A, Lentini Graziano ML, Orefice J, Patrone R, Di Mauro A, Scognamiglio G, Tatangelo F, De Bellis M, Piccirillo M, Fiore F, Stilo S, Tarotto L, Correra M, Di Lorenzo S, Capuozzo M, Avallone A, Silvestro L, Bianco A, Granata V, Federico P, Montesarchio V, Daniele B, Izzo F, Nasti G. Ottaiano A, et al. Among authors: de bellis m. Cancer Med. 2024 Feb;13(4):e6892. doi: 10.1002/cam4.6892. Cancer Med. 2024. PMID: 38457226 Free PMC article.
[Monitoring of antithrombin III in general surgery].
Testa G, Borzomati V, Rossi A, Riccini T, Giuliani A, Battista L, Pizziconi E, Capelli O, De Bellis M, Morelli A. Testa G, et al. Among authors: de bellis m. Minerva Chir. 1994 Oct;49(10):949-52. Minerva Chir. 1994. PMID: 7808669 Italian.
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).
Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, Di Gennaro E, Tatangelo F, Granata V, Cavalcanti E, Maiolino P, Bianco F, Aprea P, De Bellis M, Pecori B, Rosati G, Carlomagno C, Bertolini A, Gallo C, Romano C, Leone A, Caracò C, de Lutio di Castelguidone E, Daniele G, Catalano O, Botti G, Petrillo A, Romano GM, Iaffaioli VR, Lastoria S, Perrone F, Budillon A. Avallone A, et al. Among authors: de bellis m, de lutio di castelguidone e. BMC Cancer. 2016 Feb 8;16:69. doi: 10.1186/s12885-016-2102-y. BMC Cancer. 2016. PMID: 26857924 Free PMC article. Clinical Trial.
278 results